Objectives-To evaluate workers' exposure in a creosote impregnation plant by means of ambient and biological monitoring. Methods-Naphthalene (vapour phase) and 10 large molecular polycyclic aromatic hydrocarbons (PAHs) (particulate phase) were measured in the breathing zone air during an entire working week. 1-Hydroxypyrene (1-HP) was measured in 24 hour urine as a metabolite of the pyrene found in neat (dermal exposure) and airborne creosote.
Results-Naphthalene (0*4-4*2 mg/ml) showed 1000 times higher concentrations in air than did the particulate PAHs. In total, the geometric mean (range) of three to six ring PAHs was 4-8 (1.2-13.7) pglm3; pyrene 0-86 (0.23-2.1) ,uglm, and benzo(a)pyrene 0-012 (0.01-0.05) ,uglm'.
There was no correlation between pyrene and gaseous naphthalene. The correlations between pyrene and the other nine particulate PAHs were strong, and gave a PAH profile that was similar in all air samples: r = 0-83 (three to six ring PAHs); r = 0-81 (three ring PAHs); r = 0-78 (four to six ring PAHs). Dermal exposure was probably very high in all workers, because the daily output of urinary 1-HP exceeded the daily uptake of inhaled pyrene by 450-fold. Urinary 1-HP concentrations were very high, even on Monday mornings, when they were at their lowest (4-22 umollmol creatinine).
1-HP seldom showed any net increase over a workshift (except on Monday) due to its high concentrations (16 to 120 ,umollmol creatinine) in the morning samples. 1-HP was always lower at the end of the shift (19 to 85 ,umol/mol creatinine) than in the evening (27 to 122), and the mean (SD) change over the working week (47 (18) ) was greater than the change over Monday (35 (32) ). The timing of 1-HP sampling is therefore very important. Conclusions-Urinary 1-HP proved to be a good biomarker of exposure to three to six ring PAHs but not to airborne naphthalene. Hence, biomonitoring based on 1-HP has to be completed with exposure assessment for naphthalene as a marker for creosote volatiles that mainly enter the body through the lungs.
(Occup Environ Med 1995; 52:196-203) Keywords: occupational exposure; naphthalene; pyrene; benzo(a)pyrene; biological monitoring Creosote oil is a wood preservative derived from coal tar. Occupational exposure, which may take place by inhalation of its vapour as well as aerosol fractions, or through skin contact, is a recognised health hazard. It causes mainly toxic effects to the skin and eyes' 2 and is probably carcinogenic to humans.3 More than 100 different compounds have been analysed in creosote oils, and it has remained unclear which specific chemicals are primarily accountable for the harmful effects.'4 Analysis of polycyclic aromatic hydrocarbons (PAHs) in Finnish creosote impregnation plants5 has shown that naphthalene and its alkyl derivatives (0. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] mg/m3) were the main volatiles in the air, with concentrations 1000 times higher than the particulate PAHs (0-2-46 ,ug/m3). Pyrene was a major constituent of the large molecular PAHs (four to six rings) of both the neat and airborne creosote.
Complex chemical exposures are a health concern whenever they involve PAHs, a class of compounds considered to have human carcinogenic potential.' 6 Workers in industrial operations with high airborne concentrations of PAHs show, in particular, excess rates of lung cancer,7 '°and workers exposed specifically to creosote have an excess of lip and skin cancer." The measurement of 1-hydroxypyrene (1-HP) in urine is a method used to monitor exposure not only to its parent compound pyrene,"1'3 but also as a biomarker for total exposure to PAHs, both of occupational' 4-'9 and other origins.'520-22 The assay for 1-HP offers a method to assess the absorption of pyrene or PAHs by all routes of entry. The importance of the dermal absorption is increasingly considered in studies on occupational exposure to PAHs.2' 24 In creosote workers, the skin is probably the most important route of exposure to PAHs.5 This study was conducted outdoors in a creosote impregnation plant. The purpose was to assess: (a) the workers' exposure through inhaled air by measuring naphthalene, pyrene, benzo(a)pyrene, and eight other PAHs in the breathing zone from whole shift air samples over five days, and (b) the workers' internal exposure with the aid of the urinary 1-HP method. The study focused on different exposure routes (dermal and inhalatory), the variations in individual exposures, and the optimal urine sampling time for 1-HP measurement in an occupational biomonitoring scheme. Beerse, Belgium. fl-Glucuronidase and arylsulphatase (100 000 Fishman U/ml and 800 000 Roy U/ml) were from Boehringer, Mannheim, Germany. The purity of the solvent chemicals was of high performance liquid chromatography (HPLC) grade.
SUBJECTS AND STUDY DESIGN
The measurements were carried out in an impregnation plant, where railway ties (sleepers) were impregnated with creosote (imported from Poland). Six men with different jobs volunteered to participate in this study. The five day air sampling period was preceded and followed by a work free period of 64 hours. All workers wore leather protective gloves and cotton overalls, but no one used a respiratory protector. Employees Nos 2 and 3 worked overtime (until 6 30 pm) on Monday, which was an exception from the regular eight hours a day schedule (fig 1) .
AIR SAMPLING AND PAH ANALYSES
Personal breathing zone air samples were taken on five consecutive days in July 1987. Particulate PAHs (air sample volume 200-700 1) were collected during the whole shift (6 00 am to 2 00 pm) in one or two periods on prewashed 37 mm filters (Glassfibre Prefilter SM 13400, Sartorius AG, Goettingen, Germany) at a flow rate of 2 1/min (suction velocity 3-5 cm/s), whereafter the filters were wrapped in aluminium foil, stored in a 
DETERMINATION OF URINARY 1-HP
The method of Jongeneelen and coworkers"3 was used to analyse 1-HP in urine. Thawed urine (5 ml samples, stored for one year at -20'C without preservatives) was adjusted to pH 5 0 with iN HC1. Sodium acetate buffer (5 ml of 0-2 M, pH 5 0) containing 12-5 ,ul of f3-glucuronidase and arylsulphatase was added for enzymatic hydrolysis (complete) at 370C for three hours. Mega Bond Elut C-18 cartridges (from Analytichem International, USA) were used for solid phase sample clean up: after priming (5 ml methanol, 10 ml HO), the hydrolysed sample was loaded, washed (10 ml H2O, then 10 ml 20% acetonitrile), and the retained 1-HP was eluted in 10 ml of methanol. If needed, the eluate was concentrated 10-fold to 20-fold by evaporation (under N2 flow) and redissolved in methanol. The sample tubes were protected from light with aluminium foil. Standards of 1-HP were prepared in pooled blank urine (0, 10, 100, 250, 500, 750, 1000 nmol/l) and carried through the analytical procedures. The 1-HP was analysed with a Shimadzu HPLC system: a manual sample injector (20 pul loop), a ChromSep column (100 x 3 mm ID packed with ChromSpher PAH, Chrompack, Middelburg, Netherlands), and a fluorescence detector (from A 242 nm to A 388 nm) were used with acetonitrile-tetrahydrofuran-water (37:5:58 by volume) as the mobile phase of isocratic runs ( fig 2) . Quantification was based on peak area counts. The coefficient of variation was 4% (for pooled urine with 1-HP 1 ,umol/l n = 9) and the recovery of added standards in urine was 65%. Urinary creatinine was determined6 to correct for urine dilution and to express the 1-HP excretion per mol creatinine.
STATISTICAL ANALYSIS
The normality of the distribution of the air analysis data of the original and the log transformed PAH variables was checked. A nonparametric method (Spearman) was used for correlation analysis, because some of the transformed variables (log pyrene, P = 0-068; log of the sum of four to six ring PAHs, P = 0 0 11) were not normal.
Results
Naphthalene was determined in the vapour phase (XAD tube analysis) whereas pyrene and nine other larger PAHs were determined in the particulate phase (filter analysis) of the breathing zone air of six workers during a working week. Results represent air sampling of five days and six men (n = 30). NA = not analysed. *Data from a previous publication (Nylund, et al 1992 (7) 77 (37) 64 (23) 97 (35) 35 (32) 47 (18) 56 (25) Values are the mean (SD); *whole shift TWAs of five days; tn = three days, Monday, Wednesday and Friday; tSaturday, Sunday and Monday; difference between urine specimens, Monday end of shift (2 00 To compare, on a molar basis, the pyrene inhaled over a working day with the 1-HP excreted in urine (table 4), the respiratory pyrene dose per working day was calculated by taking into account the uptake of both particulate and gaseous pyrene (the concentration of the gaseous pyrene is known to be maximally about 50% of the total pyrene 24 25 27. Pyrene dose = Ctotai x V x T x R where Ctotal = 2 x Cparficulate pyrene concentration in air (ag/M3), V = 25 I/min ventilation rate (assumed), T = daily exposure time, R = 50% retention (assumed). Moreover, urinary excretion of 1-HP (as pmol/mol creatinine at different times or nmol/24h) did not show any significant correlation with the concentration of pyrene in the breathing zone air. As some of the workers apparently did not provide complete 24 hour urine samples on all the experimental days, we rejected uncertain data. Then, of all the possible correlations calculated by linear regression analysis, the best one was shown between daily pyrene uptake (through inhalation) and the amount of 1-HP in 24 hour urine: r = 0 34, n = 9.
Discussion
In view of the ambient and biological monitoring, it is evident that the workers were exposed both through the lungs and the skin to neat and airborne creosote. Hence, it is important to note that the chemical profiles of liquid creosotes differ from their airborne profiles, a factor complicating exposure assessment for creosote. Naphthalene is the main component in the air of workplaces where creosote is used, and it reflects well the ambient concentration of the main creosote volatiles to which, notably, pyrene and PAHs do not belong.45 This was also evident from our findings indicating that the concentrations of naphthalene vapour were about three orders of magnitude higher, and much more variable, than those of particulate pyrene in personal air samples. Not unexpectedly, the correlation of naphthalene with pyrene in air was non-existent. It is thus evident that 1-HP is not a biomarker for the major volatile fraction of airborne creosote.
Pyrene occurs characteristically with the group of large molecular PAHs, and it is found among the PAHs (chrysene, benzo(k)fluoranthene, benzo(a)pyrene, benzo(ghi)perylene) specifically implicated in the aetiology of human lung cancer.2930 A methodological difference in the PAH air sampling technique between our study and for example, the study of Tjoe Ny et al27 is that they used glass fibre filters backed by XAD-2 tubes for quantitative (indoor) trapping of PAHs in a S6derberg potroom of an aluminium smelter. They reported that, in total, 48% pyrene, 24% total PAHs, but no benzo(a)pyrene, were found on XAD tubes. Despite these methodological differences, and also the very different types of work environments with widely different airborne concentrations of pyrene (S 100 times) and benzo(a)pyrene ( < 3000 times), their findings as well as ours support the conclusion that there is a strong correlation between pyrene and the total PAHs in the air. In our study, the particulate concentrations of benzo(a)pyrene in air were even at maximum (0'05 pug/m3) low compared with its occupational limit value (10 ,ug/m3),3' and also low in view of the resultant respiratory doses (s< 03 ,ug/8 h working day) that were clearly lower than-for example, in a meal high in benzo(a)pyrene (about 5 4ug).21
Based on the 1-HP urine data, it is evident that the major uptake of carcinogenic PAHs was attributable to creosote exposure through the skin. Although ambient monitoring of benzo(a)pyrene is of indisputable value as a measure of exposure to an actual carcinogen, it was, compared with pyrene, an insensitive PAH marker for the assessment of differences between workers in external exposures to total PAHs in a work environment like the present one.
Although exposure to creosote is typically associated with working outdoors, our findings as well as those of others'4 15 25 32 point out that the urinary concentrations of 1-HP in creosote workers are very high in comparison with workers exposed to PAHs from other work environments-for example, at a coke plant,'633 34 an aluminium plant,'7 in asphalt road surfacing,'4 19 and others." 36 Also in the light of our own laboratory data, the urinary 1-HP concentrations in creosote workers were very high compared with the controls (mean (SD) 0-27 (0-24) pumol/mol creatinine, geometric mean 0-20, n = 27) measured in people from urban and rural areas in Estonia.
Zhao et al have shown that the correlations between urinary 1-HP and the ambient concentration of both pyrene (r = 0-987) and benzo(a)pyrene (r = 0 959) were highly significant in the workers of coke and steel plants, '8 whereas in our study 1-HP and pyrene did not correlate (r < 0 34).
The daily uptake of inhaled pyrene was far too small to explain the high daily urinary output of 1-HP (table 4) . This becomes more evident when it is borne in mind that in humans the urinary c put of 1-HP may maximally account for 10% of inhaled pyrene.24 After creosote oil was given to rats (4 to 80 mg/rat, intragastrically) only 5% to 3% of the pyrene therein was recovered in 24 hour urine as 1-HP (unpublished own results). In another study on rats the percentage was 10 times lower (< 0-4%).28 Hence, the observed lack of relation between 1-HP and inhaled pyrene may best be explained by additional exposure through the skin. The dirtiness of the creosote work was also obvious.
From therapeutic coal tar treatment of patients' skin it is known that pyrene is readily absorbed and excreted at high urinary concentrations of 1-HP.'2 22 32 In view of the study by van Rooij et al25 it may be concluded that skin is the main route of PAH uptake in creosote workers.
Our study showed difficulties in selecting appropriate sampling times for biological monitoring of creosote workers. It was evident that the highest concentrations of 1-HP were consistently found in late evening samples but not at the end of the shift, and that the baseline excretion concentration could be determined only after the weekend. Similar conclusions may be drawn from the data presented by van Rooij et al. 25 Assessment of daily uptake by the net increase of 1-HP in urine as a change within shift has been the common practice in many studies. In our study, however, it was hardly applicable even on Monday. When the workers had been exposed on the day before sampling, this method was not valid at all, because the 1-HP values were mostly higher in the morning than at the end of shift. Hence, the change within shift showed mostly a net decrease (Tuesday to Friday). Also Bos, Jongeneelen, and coworkers'532 studied workers who creosoted wood and found that, instead of a net increase, a decrease occurred in urinary 1-HP excretion over the workshifts. Evidently, biomonitoring based on the urine sampling both before and after work may represent rather meaningless sampling times for assessment of exposure to pyrene, especially in workers with apparent skin exposure. Another complicating factor is that in humans the excretion process of 1-HP is biphasic, showing two relatively long half lives: a shorter one (one to two days) for the readily available (for metabolism and then excretion) body pyrene and a longer one (16 days) for the slowly available component.'4 Both elimination components imply pyrene accumulation, and consistent with this the average net increase in urinary 1-HP over a workday was less than the change within a working week or within the samples taken before shifts (Friday minus Monday values).
The Monday morning concentrations of 1 -HP (1 3 (7) ,umol/mol creatinine) were very high in all the men studied, a finding characteristic for creosote workers.'4-162532 The concentrations were so high that they exceeded not only the upper limits reported for normal 1-HP excretion of unexposed non-smokers 0-66 and smokers [1] [2] [3] ,umol/mol,'4 but also the biological exposure limits of 2-3 and 4-3 ,umol/mol proposed for coke oven workers37 and for workers in a Soderberg potroom,27 respectively.
Biotransformation of pyrene into 1-HP by human liver preparations in vitro has shown large differences between people.38 It is not clear to what extent differences between people in pyrene biochemistry may cause variation in the urinary excretion rates of 1-HP in general, or in the present workers who reported different intakes of alcoholic beverages and tobacco. Alcohol consumption, medication, and age are known to have little effect on the elimination kinetics of 1-HP in humans. 16 19 Also the daily amounts of 1-HP excretion that may come from the diet2l seem relatively unimportant in creosote workers.
Although smoking is known to increase the l-HP concentrations in urine,'4 16 19 
